
Broad-based international experience developing markets, setting up operations and recognizing and commercializing disruptive technologies.
Lead healthcare company focused on genetic, cognitive and metabolic screening for Alzheimer's disease. Launched a genetic test (APOE) for Alzheimer's disease on Helix.com platform. Launched a therapeutic program for caregivers and patients with MCI or early Alzheimer's disease, including screening physician and dietitian consultations and health coaching. Developed a polygenic risk score based genetic test for Alzheimer's disease for launch on Helix.com.
Co-founded and co-directed the formation of a subsidiary company to Northwest Pathology to address Alzheimer's disease screening and therapeutic programs. Negotiated license agreement with The Buck Institute for Research on Aging covering technology for the Alzheimer's therapeutic program.
Led client support team at Northwest Pathology. Created marketing materials and programs for outreach. Worked on the medical practice managing team of directors over the practice.
Established regional offices in Abu Dhabi, UAE and Dammam, KSA to support sales and business development in the Middle East. Led sales efforts to multi-national large industrial companies for fiberglass (FRP, GRP) engineering, inspection and failure analysis.
Led marketing efforts for Microstaq, a clean-tech microelectronic product for electronic control of a/c systems and other automotive component systems. Managed IP portfolio.
Co-Founded cleantech microelectronic company. Built the team, was awarded an ATP Award, raised seed and venture capital funding. Licensed and commercialized microelectronic technology.
International sales and engineering of automotive component systems for OEM.
Fluent in Japanese